STAT3 Association with Microtubules and Its Activation Are Independent of HDAC6 Activity

被引:17
|
作者
Yan, Bing [1 ]
Xie, Songbo [1 ]
Liu, Zhu [2 ]
Luo, Youguang [1 ]
Zhou, Jun [1 ]
Li, Dengwen [1 ]
Liu, Min [2 ]
机构
[1] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China
[2] Tianjin Med Univ, Sch Basic Med Sci, Key Lab Immune Microenvironm & Dis, Minist Educ, Tianjin 300070, Peoples R China
基金
中国国家自然科学基金;
关键词
EPIDERMAL-GROWTH-FACTOR; SIGNAL TRANSDUCER; BINDING PROTEIN; DYNAMICS; APOPTOSIS; TRANSPORT;
D O I
10.1089/dna.2014.2713
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Signal transducer and activator of transcription 3 (STAT3) is an important oncogenic transcription factor residing in the cytoplasm in the resting cells. Upon stimulation, STAT3 is activated and translocated to the nucleus to regulate target genes. Although the canonical transcriptional function of STAT3 has been intensively studied, less is known about its cytoplasmic localization. In this study, by immunoprecipitation, microtubule cosedimentation, and immunofluorescence assays, we present the first evidence that cytoplasmic STAT3 interacts with both tubulin and microtubules. By using small-molecule inhibitor approaches, we further demonstrate that the localization of STAT3 on microtubules and its activation are independent of histone deacetylase 6 (HDAC6) activity. In addition, disruption of microtubule dynamics does not alter the activation and nuclear translocation of STAT3 in response to interleukin-6 treatment. These findings reveal that cytoplasmic STAT3 is physically associated with microtubules, whereas its activation and nuclear translocation are independent of microtubule dynamics, implicating that the association of STAT3 with microtubules might be involved in the regulation of noncanonical functions of STAT3 in the cytoplasm.
引用
收藏
页码:290 / 295
页数:6
相关论文
共 50 条
  • [41] Eriocalyxin B Inhibits STAT3 Signaling by Covalently Targeting STAT3 and Blocking Phosphorylation and Activation of STAT3
    Yu, Xiaokui
    He, Li
    Cao, Peng
    Yu, Qiang
    PLOS ONE, 2015, 10 (05):
  • [42] Constitutive activation of STAT3 in Sezary syndrome is independent of SHP-1
    McKenzie, R. C. T.
    Jones, C. L.
    Tosi, I.
    Caesar, J. A.
    Whittaker, S. J.
    Mitchell, T. J.
    LEUKEMIA, 2012, 26 (02) : 323 - 331
  • [43] Independent and cooperative activation of chromosomal c-fos promoter by STAT3
    Yang, E
    Lerner, L
    Besser, D
    Darnell, JE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (18) : 15794 - 15799
  • [44] Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer
    Zeleke, Tizita Z.
    Pan, Qingfei
    Chiuzan, Codruta
    Onishi, Maika
    Li, Yuxin
    Tan, Haiyan
    Alvarez, Mariano J.
    Honan, Erin
    Yang, Min
    Chia, Pei Ling
    Mukhopadhyay, Partha
    Kelly, Sean
    Wu, Ruby
    Fenn, Kathleen
    Trivedi, Meghna S.
    Accordino, Melissa
    Crew, Katherine D.
    Hershman, Dawn L.
    Maurer, Matthew
    Jones, Simon
    High, Anthony
    Peng, Junmin
    Califano, Andrea
    Kalinsky, Kevin
    Yu, Jiyang
    Silva, Jose
    NATURE CANCER, 2023, 4 (02) : 257 - +
  • [45] Inhibition of HDAC6 activity in kidney diseases: a new perspective
    Ben Ke
    Yanxia Chen
    Wei Tu
    Ting Ye
    Xiangdong Fang
    Liping Yang
    Molecular Medicine, 2018, 24
  • [46] Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer
    Tizita Z. Zeleke
    Qingfei Pan
    Codruta Chiuzan
    Maika Onishi
    Yuxin Li
    Haiyan Tan
    Mariano J. Alvarez
    Erin Honan
    Min Yang
    Pei Ling Chia
    Partha Mukhopadhyay
    Sean Kelly
    Ruby Wu
    Kathleen Fenn
    Meghna S. Trivedi
    Melissa Accordino
    Katherine D. Crew
    Dawn L. Hershman
    Matthew Maurer
    Simon Jones
    Anthony High
    Junmin Peng
    Andrea Califano
    Kevin Kalinsky
    Jiyang Yu
    Jose Silva
    Nature Cancer, 2023, 4 : 257 - 275
  • [47] Inhibition of HDAC6 activity in kidney diseases: a new perspective
    Ke, Ben
    Chen, Yanxia
    Tu, Wei
    Ye, Ting
    Fang, Xiangdong
    Yang, Liping
    MOLECULAR MEDICINE, 2018, 24 : 1 - 6
  • [48] AKT activation controls cell survival in response to HDAC6 inhibition
    M Kaliszczak
    S Trousil
    T Ali
    E O Aboagye
    Cell Death & Disease, 2016, 7 : e2286 - e2286
  • [49] AKT activation controls cell survival in response to HDAC6 inhibition
    Kaliszczak, M.
    Trousil, S.
    Ali, T.
    Aboagye, E. O.
    CELL DEATH & DISEASE, 2016, 7 : e2286 - e2286
  • [50] Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer
    Zhou, Bingyi
    Liu, Deliang
    Tan, Yuyong
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9